{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:29:41Z","timestamp":1793046581433,"version":"4.5.0"},"reference-count":137,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"13","license":[{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2020,12,14]]},"DOI":"10.1167\/tvst.9.13.20","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T15:49:55Z","timestamp":1607960995000},"page":"20","source":"Crossref","is-referenced-by-count":28,"title":["Angiotensin-(1\u20137) Expressed From Lactobacillus Bacteria Protect Diabetic Retina in Mice"],"prefix":"10.1167","volume":"9","author":[{"given":"Amrisha","family":"Verma","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengquan","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibing","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan K.","family":"Raizada","sequence":"additional","affiliation":[{"name":"Physiology & Functional Genomics, College of Medicine, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, College of Medicine, University of Florida, Gainesville, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"key":"bib1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1136\/bjophthalmol-2011-300539","article-title":"Global estimates of visual impairment: 2010","volume":"96","author":"Pascolini","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1159\/000342776","article-title":"The renin-angiotensin system in the pathophysiology of type 2 diabetes","volume":"5","author":"Goossens","year":"2012","journal-title":"Obes Facts"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1089\/ars.2012.4604","article-title":"Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease","volume":"19","author":"Dikalov","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1515\/jtim-2016-0022","article-title":"Renin-angiotensin-aldosterone system in insulin resistance and metabolic syndrome","volume":"4","author":"Das","year":"2016","journal-title":"J Transl Int Med"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.mcna.2016.08.009","article-title":"The renin angiotensin aldosterone system in obesity and hypertension: roles in the cardiorenal metabolic syndrome","volume":"101","author":"Cabandugama","year":"2017","journal-title":"Med Clin North Am"},{"key":"bib7","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2174\/0929866524666170728144357","article-title":"Renin-angiotensin system in diabetes","volume":"24","author":"Rein","year":"2017","journal-title":"Protein Pept Lett"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/bph.13742","article-title":"Significance of angiotensin 1\u20137 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system","volume":"174","author":"Karnik","year":"2017","journal-title":"Br J Pharmacol"},{"key":"bib12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1\u20137)\/MAS axis of the renin-angiotensin system: focus on angiotensin-(1\u20137)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol Rev"},{"key":"bib13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/bph.12159","article-title":"ACE2, angiotensin-(1\u20137) and Mas receptor axis in inflammation and fibrosis","volume":"169","author":"Simoes e Silva","year":"2013","journal-title":"Br J Pharmacol"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/CS20120461","article-title":"Angiotensin-(1\u20137): beyond the cardio-renal actions","volume":"124","author":"Passos-Silva","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.peptides.2014.07.002","article-title":"Angiotensin 1\u20137: a peptide for preventing and treating metabolic syndrome","volume":"59","author":"Santos","year":"2014","journal-title":"Peptides"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1080\/21623945.2015.1131881","article-title":"ACE2\/Ang 1\u20137 axis: a critical regulator of epicardial adipose tissue inflammation and cardiac dysfunction in obesity","volume":"5","author":"Patel","year":"2016","journal-title":"Adipocyte"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.metabol.2019.03.006","article-title":"Angiotensin-(1\u20137), adipokines and inflammation: inflammation and adipokines","volume":"95","author":"Lelis","year":"2019","journal-title":"Metabolism"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/mt.2011.155","article-title":"ACE2 and Ang-(1\u20137) confer protection against development of diabetic retinopathy","volume":"20","author":"Verma","year":"2012","journal-title":"Mol Ther"},{"key":"bib19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/jps.22730","article-title":"Toxicological and toxicokinetic analysis of angiotensin (1\u20137) in two species","volume":"101","author":"Mordwinkin","year":"2012","journal-title":"J Pharm Sci"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/01.HYP.32.3.496","article-title":"Converting enzyme determines plasma clearance of angiotensin-(1\u20137)","volume":"32","author":"Yamada","year":"1998","journal-title":"Hypertension"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.diabet.2016.04.004","article-title":"Impact of gut microbiota on diabetes mellitus","volume":"42","author":"Blandino","year":"2016","journal-title":"Diabetes Metab"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2337\/dc14-0769","article-title":"Insights into the role of the microbiome in obesity and type 2 diabetes","volume":"38","author":"Hartstra","year":"2015","journal-title":"Diabetes Care"},{"issue":"10","key":"bib23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11892-016-0781-z","article-title":"The role of the intestinal microbiome in type 1 diabetes pathogenesis","volume":"16","author":"Needell","year":"2016","journal-title":"Curr Diab Rep"},{"issue":"8","key":"bib24","doi-asserted-by":"publisher","first-page":"9632","DOI":"10.1111\/jdb.2019.11.issue-8","article-title":"Current understanding of the role of gut dysbiosis in type 1 diabetes","volume":"11","author":"Abdellatif","year":"2019","journal-title":"J Diabetes"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11892-018-1104-3","article-title":"Gut microbiome in obesity, metabolic syndrome, and diabetes","volume":"18","author":"Chen","year":"2018","journal-title":"Curr Diab Rep"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"e3043","DOI":"10.1002\/dmrr.v34.7","article-title":"Gut microbiome in type 1 diabetes: a comprehensive review","volume":"34","author":"Zheng","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"bib27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jnutbio.2018.10.003","article-title":"Gut microbiome and type 2 diabetes: where we are and where to go?","volume":"63","author":"Sharma","year":"2019","journal-title":"J Nutr Biochem"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1093\/nutrit\/nuw039","article-title":"Effects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysis","volume":"74","author":"Akbari","year":"2016","journal-title":"Nutr Rev"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.diabres.2016.06.014","article-title":"Probiotics for the management of type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"118","author":"Samah","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"bib30","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3390\/ijms17060928","article-title":"Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a review of human clinical trials","volume":"17","author":"Saez-Lara","year":"2016","journal-title":"Int J Mol Sci"},{"key":"bib31","doi-asserted-by":"publisher","first-page":"e4088","DOI":"10.1097\/MD.0000000000004088","article-title":"Effect of probiotics on metabolic profiles in type 2 diabetes mellitus: a meta-analysis of randomized, controlled trials","volume":"95","author":"Li","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1017\/S0007114516000076","article-title":"Glucose- and glycaemic factor-lowering effects of probiotics on diabetes: a meta-analysis of randomised placebo-controlled trials","volume":"115","author":"Sun","year":"2016","journal-title":"Br J Nutr"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.medici.2015.11.008","article-title":"Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials","volume":"52","author":"Zhang","year":"2016","journal-title":"Medicina (Kaunas)"},{"key":"bib34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/dmrr.v32.2","article-title":"Probiotics as beneficial agents in the management of diabetes mellitus: a systematic review","volume":"32","author":"Razmpoosh","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.copbio.2017.08.004","article-title":"Intestinal Lactobacillus in health and disease, a driver or just along for the ride?","volume":"49","author":"Heeney","year":"2018","journal-title":"Curr Opin Biotechnol"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1128\/MMBR.00017-08","article-title":"Genes and molecules of lactobacilli supporting probiotic action","volume":"72","author":"Lebeer","year":"2008","journal-title":"Microbiol Mol Biol Rev"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1136\/jclinpath-2015-202976","article-title":"Mechanisms and therapeutic effectiveness of lactobacilli","volume":"69","author":"Di Cerbo","year":"2016","journal-title":"J Clin Pathol"},{"key":"bib38","article-title":"The genomic basis of lactobacilli as health-promoting organisms","author":"Salvetti","journal-title":"Microbiol Spectr"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.omtm.2019.06.007","article-title":"Expression of human ACE2 in Lactobacillus and beneficial effects in diabetic retinopathy in mice","volume":"14","author":"Verma","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/fml.2010.308.issue-1","article-title":"Comparison of expression vectors in Lactobacillus reuteri strains","volume":"308","author":"Lizier","year":"2010","journal-title":"FEMS Microbiol Lett"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1167\/iovs.09-5147","article-title":"Diabetic eNOS-knockout mice develop accelerated retinopathy","volume":"51","author":"Li","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1172\/JCI4431","article-title":"A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse","volume":"103","author":"Wang","year":"1999","journal-title":"J Clin Invest"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1167\/iovs.04-1340","article-title":"The Ins2Akita mouse as a model of early retinal complications in diabetes","volume":"46","author":"Barber","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"11595","DOI":"10.1523\/JNEUROSCI.2837-05.2005","article-title":"Brn3a-expressing retinal ganglion cells project specifically to thalamocortical and collicular visual pathways","volume":"25","author":"Quina","year":"2005","journal-title":"J Neurosci"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"E2655","DOI":"10.1073\/pnas.1522014113","article-title":"Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus","volume":"113","author":"Sohn","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000333220","article-title":"Does neuronal damage precede vascular damage in subjects with type 2 diabetes mellitus and having no clinical diabetic retinopathy?","volume":"47","author":"Verma","year":"2012","journal-title":"Ophthalmic Res"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1167\/iovs.09-5041","article-title":"Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes","volume":"51","author":"van Dijk","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"bib48","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/bjophthalmol-2018-313582","article-title":"Early retinal neurovascular impairment in patients with diabetes without clinically detectable retinopathy","volume":"103","author":"Zeng","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ajo.2018.08.053","article-title":"Longitudinal relationship between retinal diabetic neurodegeneration and progression of diabetic retinopathy in patients with type 2 diabetes","volume":"196","author":"Kim","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"6722","DOI":"10.1167\/iovs.16-20289","article-title":"Beneficial effects of combined AT1 receptor\/neprilysin inhibition (ARNI) versus AT1 receptor blockade alone in the diabetic eye","volume":"57","author":"Prasad","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib51","doi-asserted-by":"publisher","first-page":"36939","DOI":"10.1074\/jbc.M104245200","article-title":"A cholera toxin B-subunit variant that binds ganglioside G(M1) but fails to induce toxicity","volume":"276","author":"Rodighiero","year":"2001","journal-title":"J Biol Chem"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"8536","DOI":"10.1073\/pnas.161273098","article-title":"A mutant cholera toxin B subunit that binds GM1- ganglioside but lacks immunomodulatory or toxic activity","volume":"98","author":"Aman","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femsle\/fnu033","article-title":"High efficiency electrotransformation of Lactobacillus casei","volume":"362","author":"Welker","year":"2015","journal-title":"FEMS Microbiol Lett"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.ajpath.2016.01.023","article-title":"Adeno-associated virus overexpression of angiotensin-converting enzyme-2 reverses diabetic retinopathy in type 1 diabetes in mice","volume":"186","author":"Dominguez","year":"2016","journal-title":"Am J Pathol"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1038\/mt.2014.179","article-title":"Oral delivery of ACE2\/Ang-(1\u20137) bioencapsulated in plant cells protects against experimental uveitis and autoimmune uveoretinitis","volume":"22","author":"Shil","year":"2014","journal-title":"Mol Ther"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1167\/iovs.14-13883","article-title":"Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice","volume":"55","author":"Qiu","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"31912","DOI":"10.1038\/srep31912","article-title":"AAV8-mediated angiotensin-converting enzyme 2 gene delivery prevents experimental autoimmune uveitis by regulating MAPK, NF-kappaB and STAT3 pathways","volume":"6","author":"Qiu","year":"2016","journal-title":"Sci Rep"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.4049\/jimmunol.1000314","article-title":"Anti-inflammatory effects of the activation of the angiotensin-(1\u20137) receptor, MAS, in experimental models of arthritis","volume":"185","author":"da Silveira","year":"2010","journal-title":"J Immunol"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1111\/j.1476-5381.2012.02105.x","article-title":"Suppressing inflammation by inhibiting the NF-kappaB pathway contributes to the neuroprotective effect of angiotensin-(1\u20137) in rats with permanent cerebral ischaemia","volume":"167","author":"Jiang","year":"2012","journal-title":"Br J Pharmacol"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.peptides.2013.05.010","article-title":"Oral angiotensin-(1\u20137) prevented obesity and hepatic inflammation by inhibition of resistin\/TLR4\/MAPK\/NF-kappaB in rats fed with high-fat diet","volume":"46","author":"Santos","year":"2013","journal-title":"Peptides"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/jcp.22940","article-title":"Angiotensin-(1\u20137) decreases LPS-induced inflammatory response in macrophages","volume":"227","author":"Souza","year":"2012","journal-title":"J Cell Physiol"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1210\/en.2011-2031","article-title":"Angiotensin-(1\u20137) administration reduces oxidative stress in diabetic bone marrow","volume":"153","author":"Mordwinkin","year":"2012","journal-title":"Endocrinology"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00592-011-0348-z","article-title":"Angiotensin-(1\u20137) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes","volume":"49","author":"Liu","year":"2012","journal-title":"Acta Diabetol"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.phrs.2012.10.014","article-title":"Angiotensin-(1\u20137) modulates renin-angiotensin system associated with reducing oxidative stress and attenuating neuronal apoptosis in the brain of hypertensive rats","volume":"67","author":"Jiang","year":"2013","journal-title":"Pharmacol Res"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"H1341","DOI":"10.1152\/ajpheart.00202.2011","article-title":"Acute and chronic angiotensin-(1\u20137) restores vasodilation and reduces oxidative stress in mesenteric arteries of salt-fed rats","volume":"301","author":"Raffai","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.2337\/db09-0782","article-title":"Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice","volume":"59","author":"Bindom","year":"2010","journal-title":"Diabetes"},{"key":"bib67","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1161\/ATVBAHA.109.200493","article-title":"Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1\u20137)","volume":"30","author":"Santos","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.2337\/db12-0792","article-title":"Angiotensin 1\u20137 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model","volume":"62","author":"Marcus","year":"2013","journal-title":"Diabetes"},{"key":"bib69","doi-asserted-by":"publisher","first-page":"E262","DOI":"10.1152\/ajpendo.90678.2008","article-title":"Chronic infusion of angiotensin-(1\u20137) improves insulin resistance and hypertension induced by a high-fructose diet in rats","volume":"296","author":"Giani","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"4677","DOI":"10.1210\/en.2016-1247","article-title":"The angiotensin-(1\u20137)\/Mas axis improves pancreatic beta-cell function in vitro and in vivo","volume":"157","author":"Sahr","year":"2016","journal-title":"Endocrinology"},{"key":"bib71","first-page":"409","article-title":"Angiotensin-converting enzyme 2-angiotensin (1\u20137)-Mas axis prevents pancreatic acinar cell inflammatory response via inhibition of the p38 mitogen-activated protein kinase\/nuclear factor-kappaB pathway","volume":"41","author":"Yu","year":"2018","journal-title":"Int J Mol Med"},{"key":"bib72","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.3892\/ijmm.2014.1917","article-title":"The angiotensin-converting enzyme 2\/angiotensin (1\u20137)\/Mas axis protects the function of pancreatic beta cells by improving the function of islet microvascular endothelial cells","volume":"34","author":"Lu","year":"2014","journal-title":"Int J Mol Med"},{"key":"bib73","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.2337\/db12-0808","article-title":"Activation of the ACE2\/angiotensin-(1\u20137)\/Mas receptor axis enhances the reparative function of dysfunctional diabetic endothelial progenitors","volume":"62","author":"Jarajapu","year":"2013","journal-title":"Diabetes"},{"key":"bib74","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1161\/HYPERTENSIONAHA.111.00202","article-title":"Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy","volume":"61","author":"Chen","year":"2013","journal-title":"Hypertension"},{"key":"bib75","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2337\/db16-1039","article-title":"Reversal of bone marrow mobilopathy and enhanced vascular repair by angiotensin-(1\u20137) in diabetes","volume":"66","author":"Vasam","year":"2017","journal-title":"Diabetes"},{"key":"bib76","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/ki.2011.381","article-title":"Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy","volume":"81","author":"Batlle","year":"2012","journal-title":"Kidney Int"},{"key":"bib77","doi-asserted-by":"publisher","first-page":"F1606","DOI":"10.1152\/ajprenal.00063.2012","article-title":"Angiotensin-(1\u20137) attenuates diabetic nephropathy in Zucker diabetic fatty rats","volume":"302","author":"Giani","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"bib78","doi-asserted-by":"publisher","first-page":"F1271","DOI":"10.1152\/ajprenal.00065.2010","article-title":"Attenuating effect of angiotensin-(1\u20137) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)\/Ta mice","volume":"300","author":"Moon","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"bib79","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2337\/db09-1218","article-title":"Human recombinant ACE2 reduces the progression of diabetic nephropathy","volume":"59","author":"Oudit","year":"2010","journal-title":"Diabetes"},{"key":"bib80","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/ki.2012.83","article-title":"Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice","volume":"82","author":"Nadarajah","year":"2012","journal-title":"Kidney Int"},{"key":"bib81","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1358\/mf.2010.32.1.1434160","article-title":"Ameliorative potential of angiotensin1\u20137\/Mas receptor axis in streptozotocin-induced diabetic nephropathy in rats","volume":"32","author":"Singh","year":"2010","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"bib82","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1042\/CS20140329","article-title":"Angiotensin-(1\u20137) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice","volume":"128","author":"Shi","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"bib83","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/ki.2014.274","article-title":"Angiotensin(1\u20137) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade","volume":"87","author":"Zhang","year":"2015","journal-title":"Kidney Int"},{"key":"bib84","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jacc.2011.09.071","article-title":"Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy","volume":"59","author":"Dong","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"bib85","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1113\/expphysiol.2011.063461","article-title":"Chronic activation of endogenous angiotensin-converting enzyme 2 protects diabetic rats from cardiovascular autonomic dysfunction","volume":"97","author":"Murca","year":"2012","journal-title":"Exp Physiol"},{"key":"bib86","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.regpep.2012.05.093","article-title":"Oral administration of an angiotensin-converting enzyme 2 activator ameliorates diabetes-induced cardiac dysfunction","volume":"177","author":"Murca","year":"2012","journal-title":"Regul Pept"},{"key":"bib87","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1177\/1753944711409281","article-title":"Beneficial effects of angiotensin (1\u20137) in diabetic rats with cardiomyopathy","volume":"5","author":"Singh","year":"2011","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"bib88","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1042\/CS20130344","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications","volume":"126","author":"Patel","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"bib89","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1128\/AEM.57.8.2413-2417.1991","article-title":"Cloning and nucleotide sequence of the Lactobacillus casei lactate dehydrogenase gene","volume":"57","author":"Kim","year":"1991","journal-title":"Appl Environ Microbiol"},{"key":"bib90","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/pedi.2016.17.issue-7","article-title":"Modulation of type 1 and type 2 diabetes risk by the intestinal microbiome","volume":"17","author":"Paun","year":"2016","journal-title":"Pediatr Diabetes"},{"key":"bib91","doi-asserted-by":"publisher","first-page":"17737","DOI":"10.3748\/wjg.v20.i47.17737","article-title":"Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective","volume":"20","author":"Han","year":"2014","journal-title":"World J Gastroenterol"},{"key":"bib92","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11892-013-0409-5","article-title":"Human intestinal microbiota and type 1 diabetes","volume":"13","author":"Vaarala","year":"2013","journal-title":"Curr Diab Rep"},{"key":"bib93","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1097\/MED.0b013e3283628569","article-title":"The interplay between the gut microbiota and the immune system in the mechanism of type 1 diabetes","volume":"20","author":"Zipris","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"bib94","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.2174\/1381612822666160922165706","article-title":"Intestinal dysbiosis, gut hyperpermeability and bacterial translocation: missing links between depression, obesity and type 2 diabetes","volume":"22","author":"Slyepchenko","year":"2016","journal-title":"Curr Pharm Des"},{"key":"bib95","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/07853890.2016.1222449","article-title":"Is there a role for gut microbiota in type 1 diabetes pathogenesis?","volume":"49","author":"Bibbo","year":"2017","journal-title":"Ann Med"},{"key":"bib96","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.trsl.2016.09.001","article-title":"Where genes meet environment-integrating the role of gut luminal contents, immunity and pancreas in type 1 diabetes","volume":"179","author":"Scott","year":"2017","journal-title":"Transl Res"},{"key":"bib97","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jaut.2016.02.004","article-title":"Immune recognition and response to the intestinal microbiome in type 1 diabetes","volume":"71","author":"Paun","year":"2016","journal-title":"J Autoimmun"},{"key":"bib98","doi-asserted-by":"publisher","first-page":"590","DOI":"10.4049\/jimmunol.1601519","article-title":"The influence of the microbiome on type 1 diabetes","volume":"198","author":"Paun","year":"2017","journal-title":"J Immunol"},{"key":"bib99","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1007\/s00125-017-4278-3","article-title":"The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities","volume":"60","author":"Brunkwall","year":"2017","journal-title":"Diabetologia"},{"key":"bib100","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ebiom.2019.06.031","article-title":"Microbiome and type 1 diabetes","volume":"46","author":"Siljander","year":"2019","journal-title":"EBioMedicine"},{"issue":"4","key":"bib101","doi-asserted-by":"publisher","first-page":"995","DOI":"10.3390\/ijms19040995","article-title":"Gut microbiota and type 1 diabetes","volume":"19","author":"Han","year":"2018","journal-title":"Int J Mol Sci"},{"key":"bib102","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11892-017-0933-9","article-title":"Modulation of type 1 diabetes risk by the intestinal microbiome","volume":"17","author":"Knip","year":"2017","journal-title":"Curr Diab Rep"},{"issue":"2","key":"bib103","first-page":"32","article-title":"The role of gut microbiota in obesity and type 2 and type 1 diabetes mellitus: new insights into \"old\" diseases","volume":"6","author":"Harsch","year":"2018","journal-title":"Med Sci (Basel)"},{"key":"bib104","doi-asserted-by":"publisher","first-page":"102590","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"EBioMedicine"},{"key":"bib105","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.2337\/db18-0158","article-title":"Restructuring of the gut microbiome by intermittent fasting prevents retinopathy and prolongs survival in db\/db mice","volume":"67","author":"Beli","year":"2018","journal-title":"Diabetes"},{"key":"bib106","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/CIRCRESAHA.119.315743","article-title":"Bone marrow-derived cells restore functional integrity of the gut epithelial and vascular barriers in a model of diabetes and ACE2 deficiency","volume":"125","author":"Duan","year":"2019","journal-title":"Circ Res"},{"key":"bib107","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/978-3-319-75402-4","article-title":"The role of microbiota in retinal disease","volume":"1074","author":"Rowan","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"bib108","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/dmrr.v29.2","article-title":"Probiotics as potential biotherapeutics in the management of type 2 diabetes - prospects and perspectives","volume":"29","author":"Panwar","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"bib109","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12020-017-1433-z","article-title":"Probiotic strains and mechanistic insights for the treatment of type 2 diabetes","volume":"58","author":"Hampe","year":"2017","journal-title":"Endocrine"},{"issue":"3","key":"bib110","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/microorganisms7030067","article-title":"Probiotics and prebiotics for the amelioration of type 1 diabetes: present and future perspectives","volume":"7","author":"Mishra","year":"2019","journal-title":"Microorganisms"},{"key":"bib111","doi-asserted-by":"publisher","first-page":"e3213","DOI":"10.1002\/dmrr.v36.1","article-title":"Probiotics for the treatment of type 2 diabetes: a review of randomized controlled trials","volume":"36","author":"Tiderencel","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"bib112","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1080\/10408398.2018.1547268","article-title":"Using probiotics for type 2 diabetes mellitus intervention: advances, questions, and potential","volume":"60","author":"Sun","year":"2020","journal-title":"Crit Rev Food Sci Nutr"},{"key":"bib113","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"bib114","article-title":"Probiotics, gut microbiota, and their influence on host health and disease","author":"Sanchez","journal-title":"Mol Nutr Food Res"},{"key":"bib115","article-title":"Recent advances and understanding of using probiotic-based interventions to restore homeostasis of the microbiome for the prevention\/therapy of bacterial diseases","author":"Suchodolski","journal-title":"Microbiol Spectr"},{"key":"bib116","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-3-319-31248-4","article-title":"Manipulation of the microbiota using probiotics","volume":"902","author":"Grimm","year":"2016","journal-title":"Adv Exp Med Biol"},{"key":"bib117","doi-asserted-by":"publisher","first-page":"7885","DOI":"10.1021\/acs.jafc.5b02404","article-title":"Modulation of gut microbiota-brain axis by probiotics, prebiotics, and diet","volume":"63","author":"Liu","year":"2015","journal-title":"J Agric Food Chem"},{"key":"bib118","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10787-014-0201-4","article-title":"Probiotics, prebiotics and the gastrointestinal tract in health and disease","volume":"22","author":"Vitetta","year":"2014","journal-title":"Inflammopharmacology"},{"key":"bib119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.medmal.2013.10.002","article-title":"Probiotics, gut microbiota and health","volume":"44","author":"Butel","year":"2014","journal-title":"Med Mal Infect"},{"key":"bib120","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jped.2014.08.005","article-title":"Probiotics: an update","volume":"91","author":"Vandenplas","year":"2015","journal-title":"J Pediatr (Rio J)"},{"key":"bib121","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bpg.2015.12.001","article-title":"Probiotics: definition, scope and mechanisms of action","volume":"30","author":"Reid","year":"2016","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"bib122","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/gerona\/glz222","article-title":"Therapeutic delivery of Ang(1\u20137) via genetically modified probiotic: a dosing study","volume":"75","author":"Carter","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"bib123","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1007\/s11357-020-00196-y","article-title":"Angiotensin (1\u20137) delivered orally via probiotic, but not subcutaneously, benefits the gut-brain axis in older rats","volume":"42","author":"Buford","year":"2020","journal-title":"Geroscience"},{"key":"bib124","doi-asserted-by":"publisher","first-page":"e68731","DOI":"10.1371\/journal.pone.0068731","article-title":"Lactobacillus paracasei comparative genomics: towards species pan-genome definition and exploitation of diversity","volume":"8","author":"Smokvina","year":"2013","journal-title":"PLoS One"},{"key":"bib125","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/1871530314666141216121349","article-title":"Role of probiotics and functional foods in health: gut immune stimulation by two probiotic strains and a potential probiotic yoghurt","volume":"15","author":"Maldonado Galdeano","year":"2015","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"bib126","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.disamonth.2015.03.011","article-title":"Probiotics","volume":"61","author":"Mizock","year":"2015","journal-title":"Dis Mon"},{"issue":"suppl 1","key":"bib127","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/MCG.0000000000000350","article-title":"Probiotics in 2015: their scope and use","volume":"49","author":"Sanders","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"bib128","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3945\/jn.114.205989","article-title":"Preventive and therapeutic effects of Lactobacillus paracasei B21060-based synbiotic treatment on gut inflammation and barrier integrity in colitic mice","volume":"145","author":"Simeoli","year":"2015","journal-title":"J Nutr"},{"key":"bib129","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3920\/BM2013.0041","article-title":"Oral administration of Lactobacillus paracasei alleviates clinical symptoms of colitis induced by dextran sulphate sodium salt in BALB\/c mice","volume":"5","author":"Pan","year":"2014","journal-title":"Benef Microbes"},{"key":"bib130","doi-asserted-by":"publisher","first-page":"807483","DOI":"10.1155\/2011\/807483","article-title":"Lactobacillus paracasei reduces intestinal inflammation in adoptive transfer mouse model of experimental colitis","volume":"2011","author":"Oliveira","year":"2011","journal-title":"Clin Dev Immunol"},{"key":"bib131","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1039\/C6FO00831C","article-title":"Antidiabetic (type 2) effects of Lactobacillus G15 and Q14 in rats through regulation of intestinal permeability and microbiota","volume":"7","author":"Tian","year":"2016","journal-title":"Food Funct"},{"key":"bib132","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1039\/C8FO00081F","article-title":"Administration of Lactobacillus paracasei ameliorates type 2 diabetes in mice","volume":"9","author":"Dang","year":"2018","journal-title":"Food Funct"},{"key":"bib133","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s00394-017-1482-3","article-title":"Chronic treatment with prebiotics, probiotics and synbiotics attenuated cardiac dysfunction by improving cardiac mitochondrial dysfunction in male obese insulin-resistant rats","volume":"57","author":"Tunapong","year":"2018","journal-title":"Eur J Nutr"},{"key":"bib134","doi-asserted-by":"publisher","first-page":"e1900457","DOI":"10.1002\/mnfr.v63.22","article-title":"Ameliorative effects of probiotic Lactobacillus paracasei NL41 on insulin sensitivity, oxidative stress, and beta-cell function in a type 2 diabetes mellitus rat model","volume":"63","author":"Zeng","year":"2019","journal-title":"Mol Nutr Food Res"},{"key":"bib135","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.micpath.2016.02.005","article-title":"Akkermansia muciniphila and its role in regulating host functions","volume":"106","author":"Derrien","year":"2017","journal-title":"Microbial Pathogenesis"},{"key":"bib136","first-page":"8075","article-title":"Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders","volume":"23","author":"Macchione","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"bib137","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3389\/fmicb.2020.00219","article-title":"Function of Akkermansia muciniphila in obesity: interactions with lipid metabolism, immune response and gut systems","volume":"11","author":"Xu","year":"2020","journal-title":"Front Microbiol"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2772059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T07:04:37Z","timestamp":1697353477000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2772059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":137,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.9.13.20","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,14]]}}}